Finance, Business, Networking | Pexels by Leeloo Thefirst
Finance, Business, Networking | Pexels by Leeloo Thefirst
The Blood and Marrow Transplant (BMT) Program at Northside Hospital Cancer Institute — one of the largest and most comprehensive bone marrow transplant programs in the Southeast — again has been recognized as having among the very best survival outcomes in the U.S. for bone marrow transplants.
It's the 14th consecutive year (2009-22) for the Northside BMT Program to earn this recognition. No other transplant program in the nation has achieved this milestone.
The Centers for International Blood and Marrow Transplant Research (CIBMTR) provided the data in its Final 2022 Transplant Center Survival Report, which tabulated patient survival following transplantation at 175 adult and pediatric transplant centers in the U.S.
Patients transplanted at the BMT Program at Northside had an 81.3% one-year survival rate, which places the program in the 95th percentile for survival when compared to risk-adjusted predicted outcome (p< 0.5). Northside is the only center in Georgia to achieve outcomes statistically superior to expectations and is one of only 15 centers in the U.S. to achieve this status for the current 2022 reporting cycle. No other center in the nation has a streak of 14 consecutive annual reporting cycles with superior outcomes.
Original source can be found here.
Alerts Sign-up